1. Homogeneous aqueous solution nuclear reactors for the production of Mo-99 and other short lived radioistotopes. IAEA-TECDOC-160;Adelfang,2008
2. Analytical report, 2008. Status and Perspectives of Development of Nuclear Medicine and Ray Therapy in Russia in the Light of World Tendencies. Moscow, pp. 1–100 (〈www.oprf.ru/files/yad_medicine.doc〉) (in Russian).
3. Unexpected exracardiac findings during Rubidium-82 (Rb-82) myocardial positron emission tomography (PET) perfusion imaging: three years of experience;Arcila;J. Nucl. Med.,2010
4. Betenekov, N.D. et al., 2002. Inorganic sorbent for molybdenum-99 extraction from irradiated uranium solution and its method of use. U.S. patent 6337055.
5. Bokshits, V., 2011. Program of Development of Nuclear Medicine and Radiopharmacy Ensures Isotope Demand. Energy expert center (〈http://www.energy-experts.ru/comments3655.html〉) (in Russian).